Skip to main content
PMC home page
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2018 Feb 27;9:331. doi: 10.3389/fmicb.2018.00331

Fitness Advantage of mcr-1–Bearing IncI2 and IncX4 Plasmids in Vitro

Renjie Wu 1,‡, Ling-xian Yi 1,‡, Lin-feng Yu 1, Jing Wang 1, Yiyun Liu 1, Xiaojie Chen 1,†, Luchao Lv 1, Jun Yang 1, Jian-Hua Liu 1,*
PMCID: PMC5835064  PMID: 29535696

Abstract

The objective of this study was to assess the impact of diverse plasmids bearing colistin resistance gene mcr-1 on host fitness. Forty-seven commensal E. coli isolates recovered from the pig farm where mcr-1 was first identified were screened for mcr-1. mcr-1-bearing plasmids were characterized by sequencing. The fitness impact of mcr-1-bearing plasmids was evaluated by in vitro competition assays. Twenty-seven (57.5%) E. coli isolates were positive for mcr-1. The mcr-1 genes were mainly located on plasmids belonging to IncI2 (n = 5), IncX4 (n = 11), IncHI2/ST3 (n = 8), IncFII (n = 2), and IncY (n = 2). InHI2 plasmids also carried other resistance genes (floR, blaCTX−M, and fosA3) and were only detected in isolates from nursery pigs. Sequences of the representative mcr-1–bearing plasmids were almost identical to those of the corresponding plasmid types reported previously. An increase in the fitness of IncI2- and IncX4-carrying strains was observed, while the presence of IncHI2, IncFII and IncY plasmids showed a fitness cost although an insignificant fitness increase was initially observed in IncFII or IncY plasmids-containing strains. Acquisition of IncI2-type plasmid was more beneficial for host E. coli DH5α than either IncHI2 or IncX4 plasmid, while transformants with IncHI2-type plasmid presented a competitive disadvantage against IncI2 or IncX4 plasmid containing strains. In conclusion, IncI2, IncX4, and IncHI2 were the major plasmid types driving the dissemination of mcr-1 in this farm. Increased fitness or co-selection by other antimicrobials might contribute to the further dissemination of the three epidemic mcr-1–positive plasmids (IncI2, IncX4, and IncHI2) in this farm and worldwide.

Keywords: Escherichia coli, mcr-1, colistin, plasmid, fitness

Introduction

The ongoing emergence and spread of multidrug-resistant and even pan drug-resistant Enterobacteriaceae has led the world into a post-antibiotic era (Bush et al., 2011; Laxminarayan et al., 2013). Under these circumstances, colistin, as the last resort for the treatment of infections with multidrug-resistant (MDR) bacteria, has gained extensive attention. However, colistin resistance has been found in gram-negative bacteria. Most importantly, transferable colistin resistance, which was first found to be mediated by mcr-1, emerged in 2015 (Liu et al., 2016). Since then, research groups have increasingly screened for the presence of mcr-1, and this gene has thus far been detected in diverse Enterobacteriaceae species (Klebsiella pneumoniae, Salmonella, Shigella sonnei, Enterobacter spp, Kluyvera ascorbata, Citrobacter braakii, Raoultella ornithinolytica) from the environment, food, humans, livestock, wildlife, companion animals, rivers, or vegetables in widespread geographical locations (Baron et al., 2016; Al-Tawfiq et al., 2017; Luo et al., 2017; Poirel et al., 2017).

Previous literatures have suggested that IncI2, IncX4, and IncHI2 are responsible for the worldwide distribution of mcr-1 gene (Doumith et al., 2016; Cui et al., 2017; Li et al., 2017). IncI2, IncX4 and IncHI2 plasmids accounted for over 90% of reported mcr-1-bearing plasmids (Matamoros et al., 2017). However, mechanism of these three plasmid types being prevalent is still unclear, and the systematic evaluation regarding mcr-1-bearing plasmids carriage on its host fitness was scarce.

The mcr-1 gene was first discovered in a pig E. coli strain SHP45 from a commercial farm where the prevalence of colistin resistance among E. coli isolates recovered from the pigs was over 50% (Liu et al., 2016). In this study, we aimed to characterize the molecular trait of mcr-1–positive plasmids among Escherichia coli strains from pigs of different ages in the farm where mcr-1 was first identified and to evaluate the impact of diverse natural mcr-1–bearing plasmids on host fitness through in vitro competition assays.

Materials and methods

Sampling and bacterial isolates

Sixty rectal swab samples from pigs of different age groups (50 days old, 70 days old, 4 months old, and 5 months old) were collected from a pig farm located in Shanghai in July 2013, at which mcr-1 was first reported. The antimicrobial application data at this farm over the past year were provided by the veterinarians (Table S1). The isolates were identified by conventional biochemical tests and confirmed by matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) (Shimadzu, Japan).

Antimicrobial susceptibility test

The antimicrobial susceptibility test was performed using either the agar dilution method or broth microdilution method (limited to colistin), and the results were interpreted according to Clinical and Laboratory standards Institute (CLSI) recommendations (Clinical and Laboratory Standards Institute, 2017). The epidemiological cut-off value (http://mic.eucast.org/Eucast2/) for florfenicol and neomycin was >16 and > 8 mg/L, respectively. E. coli ATCC25922 was used as the reference strain.

Detection of antimicrobial resistance genes

The strains were screened for the presence of mcr-1 by PCR amplification using primers described previously (Table S2; Liu et al., 2016). Additionally, the mcr-1–positive isolates were also PCR-screened for the presence of the blaCTX−M, fosA3, oqxAB, and floR genes (Liu et al., 2007; Zhao et al., 2010; Hou et al., 2012; Li et al., 2015). PCR results were confirmed by sequencing.

Molecular typing

Pulse-field gel electrophoresis (PFGE) was conducted to identify the clonal relationship among the mcr-1–positive isolates. The DNA of the isolates was digested with the restriction enzyme XbaI and then subjected to PFGE analysis using the CHEF-MAPPER System (Bio-Rad Laboratories, Hercules, CA, USA). The results were interpreted according to the criteria reported previously (Tenover et al., 1995).

Conjugation and transformation experiments

Conjugation experiments were performed by the broth mating method with E. coli C600 (streptomycin resistant) used as the recipient strain. The transconjugants were selected on MacConkey agar plates supplemented with colistin (2 mg/L) and streptomycin (3,000 mg/L). Transfer frequencies were calculated as the ratio of transconjugants over recipient cells. Plasmids that failed to transfer by conjugation were extracted from the mcr-1–positive E. coli strains and transformed into the E. coli recipient strain DH5α (Takara) by the electroporation. Transformants were selected on Luria-Bertani agar plates containing 2 mg/L colistin. The antimicrobial susceptibility of the transconjugants/transformants was determined by either the agar dilution method or broth microdilution method, and the presence of blaCTX−M, fosA3, oqxAB and floR genes in the transconjugants/transformants was confirmed by PCR.

Plasmid analysis

To determine the location of the mcr-1 gene and the size of the plasmid, S1 nuclease pulsed-field gel electrophoresis (S1-PFGE) combined with Southern blotting was conducted. The samples were digested with the restriction enzyme S1 and separated using the CHEF-MAPPER System. The gels were run at 6.0 V/cm with an initial/final switch time of 2.16 s/63.8 s for 19 h. The plasmid DNA was transferred and cross-linked to positively charged nylon membranes (Roche Diagnostics) and hybridized using DIG-labeled mcr-1 gene as the probe. PCR-based replicon typing (PBRT) was performed on all transconjugants/transformants, as described previously (Carattoli et al., 2005). Plasmid double locus sequence typing (pDLST) and replicon sequence typing (RST) were performed to better characterize the IncHI2 and IncFII plasmids, respectively (Garcia-Fernandez and Carattoli, 2010; Villa et al., 2010).

The genomic DNA of the transconjugants of SHP8, SHP10, SHP16, SHP23, SHP26, SHP41, SHP47, SHP48, SHP49, and SHP50 was extracted and sequenced using Illumina Hiseq 2000 (Illumina, San Diego, CA, USA). Sequence reads were assembled into contigs using SOAP denovo version 2.04. The contigs of 10 mcr-1–bearing plasmids, designated as pHNSHP8, pHNSHP10, pHNSHP16, pHNSHP23, pHNSHP26, pHNSHP41, pHNSHP47, pHNSHP48, pHNSHP49, and pHNSHP50, respectively, were separated from the chromosomal contigs and compared with our previously reported plasmids pHNSHP45 (Liu et al., 2016) and pHNSHP45-2 (Zhi et al., 2016) using Blast (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and BRIG (Alikhan et al., 2011). Related mcr-1-carrying IncX4 plasmids were used to guide PCR-based gap closure, and Sanger sequencing was performed to assemble contigs of pHNSHP10, pHNSHP23, and pHNSHP49 into complete plasmids. The complete sequences of pHNSHP10, pHNSHP23, and pHNSHP49 and the partial sequences of the remaining seven plasmids were analyzed and annotated using RAST (Aziz et al., 2008), IS finder (https://www-is.biotoul.fr//), ResFinder (https://cge.cbs.dtu.dk//services/ResFinder/), and the Gene Construction Kit 4.0 (Textco BioSoftware, Inc., Raleigh, NC, USA).

Genetic context of mcr-1

The surrounding regions flanking mcr-1 and the insertion site of mcr-1 in the plasmids were determined by PCR mapping and sequencing with primers listed in Table S3.

Plasmid stability and growth kinetics

The stability of the mcr-1–positive plasmids was investigated in vitro according to a previously described protocol (Bryksin and Matsumura, 2010; Wang et al., 2017). In brief, transconjugants E. coli DH5α/pHNSHP45, E. coli DH5α/pHNSHP45-2, E. coli DH5α/pHNSHP23, E. coli DH5α/pHNSHP17, and E. coli DH5α/ pHNSHP24 were propagated by serial transfer for 14 days of passage. Periodically, the culture broths were serially diluted in 0.85% saline and plated onto LB agar without colistin. Approximately 100 colonies were randomly chosen and replica plated onto LB agar plates with colistin. ~50 colonies grown on colistin-supplemented agar were randomly selected to confirm the presence of mcr-1 and the corresponding replicon type by PCR assay (Table S2; Carattoli et al., 2005). The growth kinetics of E. coli DH5α and its transformants carrying the plasmids pHNSHP23, pHNSHP45-2, pHNSHP45, pHNSHP17 and pHNSHP24 were studied by inoculation in 100 mL of fresh LB broth. The starting OD600 value was 0.01. Bacterial growth was recorded by monitoring OD600 every 1 h for 12 h at 37°C. Experiments were repeated in three separate assays.

Competition experiments in vitro

To assess the fitness effect of mcr-1-bearing plasmids on bacterial host, E. coli plasmid-harboring transformants (E. coli DH5α with pHNSHP23, pHNSHP45-2, pHNSHP45, pHNSHP17 and pHNSHP24 representing IncX4, IncHI2, IncI2, IncY, and IncFII, respectively) was used to compete against plasmid-free E. coli DH5α. To further distinguish, plasmid-plasmid competition experiments were conducted between pair transformants (pHNSHP45/pHNSHP45-2, pHNSHP23/pHNSHP45-2, and pHNSHP45/pHNSHP23) in fresh LB as previously described (Foucault et al., 2009; Machuca et al., 2014). The overnight cultures of two comparable competitors were mixed at a rate of 1:1 at 0 h and 10−3 diluted into LB broth. The mixture was then incubated for 24 h, and then the mixed population was again 1000-fold diluted into fresh LB broth. This procedure was repeated until the competition experiment had lasted for 96 h. The total number of bacteria were determined by spreading properly diluted samples of each competition mixture on LB agar at 0, 24, 48, 72, and 96 h, and an average of 100 colonies were replica plated on LB agar supplemented with 2 mg/L colistin. The percentage of colistin resistant cells was deduced by counting the viable bacteria on colistin-supplemented LB agar, which were also analyzed by colony PCR targeting mcr-1 gene and corresponding replicon type (Table S2; Carattoli et al., 2005).

The formula RF = (log10 S1dt − log10 S1d0) / (log10 S2dt − log10 S2d0) (Machuca et al., 2014) was used to calculate the relative fitness (RF), where S1 and S2 represent cfu densities of the constructed isolates/transformants and its control isolates (t is time in days). If there exists a fitness cost between the competitors, then RF < 1; if not, RF > 1. Statistical analysis was carried out via the software GraphPad Prism 5.0 (GraphPad Software Inc., La Jolla, CA).

Nucleotide sequence accession numbers

The complete nucleotide sequences of pHNSHP10, pHNSHP23, and pHNSHP49, and the partial sequences of mcr-1-bearing plasmids pHNSHP8, pHNSHP16, pHNSHP26, pHNSHP47, pHNSHP48, and pHNSHP50 were deposited in GenBank under the accession numbers MF774182, MF774184, MF774188, MF774181, MF774183, MF774185, MF774186, MF774187, and MF774189, respectively.

Results

Incidence of mcr-1

Forty-seven E. coli isolates were recovered from the 60 samples obtained from pigs of different ages in the farm. Among them, 27 (57.5%) showed resistance to colistin (>2 mg/L) and were positive for mcr-1 (Table 1).

Table 1.

Details of the mcr-1 positive E. coli isolates from swine.

Isolates Age group PFGE pattern MIC of colistin (mg/L) Other resistance phenotypec Genetic environment Replicon Conjugation frequency Plasmid size (kb) Other resistance gene (s)
SHP50 50 days F 4 FFC, TET, CIP, SXT IncI2-mcr-1-IncI2 IncI2 4 × 10−4 ~60 oqxAB, floR
SHP52 50 days G 4 AMP, FFC, NEO, TET, CIP IncX4-mcr-1-IncX4 IncX4 1.27 × 10−3 ~33 oqxAB, floR
SHP49, SHP36 50 days E 8 AMP, FFC, GEN, NEO, CIP, SXT IncX4-mcr-1-IncX4 IncX4 2 × 10−5, 1.78 × 10−4 ~33 oqxAB, floR
SHP47 50 days P 8 AMP, CTX, FFC, FOS, GEN, NEO, SXT ISApI1-mcr-1-IncHI2 IncHI2 (ST3) 2 × 10−6 ~244 blaCTX−M−14, floR, fosA3, oqxAB
SHP48 50 days Q 8 NEO, FFC, SXT, TET, CIP ISApI1-mcr-1- IncHI2 IncHI2 (ST3) – ~275 oqxAB, floR
SHP39 50 days N 4 AMP, CTX, FFC, FOS, GEN, NEO, TET, SXT ISApI1-mcr-1-IncHI2 IncHI2 (ST3) 2 × 10−6 ~244 blaCTX−M−14, floR, fosA3, oqxAB
SHP41 50 days O 4 AMP, CTX, FFC, FOS, TET, SXT ISApI1-mcr-1- ISApI1, IncX4-mcr-1-IncX4 IncHI2 (ST3), IncX4 – ~238, ~33 blaCTX−M−15, floR, fosA3, oqxAB
SHP51 50 days R 8 AMP, CTX, FFC, FOS, GEN, NEO, TET, SXT ISApI1-mcr-1-IncHI2, ISApI1-mcr-1- ISApI1 IncHI2 (ST3) 2.90 × 10−5 ~244, chromosome blaCTX−M−14, floR, fosA3
SHP43 50 days D3 8 AMP, CTX, FFC, FOS, GEN, NEO, CIP, SXT ISApI1-mcr-1-IncHI2 IncY-IncHI2 – ~350 blaCTX−M−14, floR, fosA3, oqxAB
SHP45 50 days D2 8 AMP, CTX, FFC, FOS, GEN, NEO, TET, CIP, SXT ISApI1-mcr-1-IncI2, ISApI1-mcr-1-IncHI2 IncI2, IncHI2 (ST3) – ~64, ~244 blaCTX−M−14, floR, fosA3, oqxAB
SHP26 70 days D1 8 AMP, CTX, FFC, FOS, GEN, NEO, TET, CIP, SXT ISApI1-mcr-1-IncHI2 IncHI2 (ST3) 6.84 × 10−5 ~244 blaCTX−M−14, floR, fosA3, oqxAB
SHP46a 50 days K2 4 AMP, FFC, NEO, SXT ISApI1-mcr-1-? ND – ~104 oqxAB, floR
SHP22 70 days K1 8 AMP, FFC, NEO, SXT ISApI1-mcr-1- ISApI1 F29:A-:B- – ~78 floR
SHP17 70 days J 4 AMP, CTX, FFC, NEO, TET, SXT unknown IncY 8.64 × 10−6 ~83 blaCTX−M−55, oqxAB, floR
SHP28 70 days J 8 AMP, CTX, FFC, NEO, TET, SXT IncX4-mcr-1-IncX4 IncX4 – ~33 oqxAB, floR
SHP31a 70 days L 8 FFC, NEO, TET, CIP, SXT ISApI1-mcr-1- ISApI1 ND – ~80 oqxAB, floR
SHP24 70 days L 8 FFC, NEO, TET, SXT ISApI1-mcr-1- ISApI1 F53:A-:B- – ~80 floR
SHP33a 70 days M 16 FFC, NEO, TET, CIP, SXT unknown NA – chromosome oqxAB, floR
SHP23 70 days smeared 8 AMP, FFC, NEO, TET, CIP, SXT IncX4-mcr-1-IncX4 IncX4 5.43 × 10−5 ~33 oqxAB, floR
SHP32 70 days A 4 AMP, FFC, TET, CIP, SXT IncX4-mcr-1-IncX4 IncX4 – ~33 oqxAB, floR
SHP14b 4 months A 8 AMP, FFC, GEN, TET, CIP, SXT IncX4-mcr-1-IncX4 IncX4 – ~33 oqxAB, floR
SHP16 4 months I 8 TET, SXT ISApI1-mcr-1-IncI2 IncI2 8.12 × 10−5 ~64 oqxAB
SHP10 4 months H 8 AMP, FFC, NEO, TET, SXT IncX4-mcr-1-IncX4 IncX4 5 × 10−6 ~33 oqxAB, floR
SHP8 4 months C 8 AMP, FFC, NEO, TET, SXT ISApI1-mcr-1-IncI2 IncI2 – ~62 oqxAB, floR
SHP7 4 months B 4 AMP, CTX, FOX, FFC, TET, SXT IncX4-mcr-1-IncX4, ISApI1-mcr-1-IncI2 IncX4, IncI2 – ~33, ~62 oqxAB, floR, blaCMY−2
SHP59 5 months S 4 AMP, FFC, TET, SXT IncX4-mcr-1-IncX4 IncX4 – ~33 oqxAB, floR
Open in a new tab
a

Isolates failed to get transconjugants.

b

Isolates successfully get transformant by the electroporation.

c

AMP, ampicillin; CIP, ciprofloxacin; CTX, cefotaxime; FFC, florfenicol; FOS, fosfomycin; GEN, gentamicin; NEO, neomycin; SXT, sulfamethoxazole-trimethoprim; TET, tetracycline. Patterns transferred by conjugation are underlined.

Characterization of mcr-1–positive E. coli isolates

PFGE was successfully performed in 26 of the 27 mcr-1–positive E. coli isolates, which were grouped into 19 clonal patterns, designated A to S (Table 1 and Table S1). This result suggested that the dissemination of the mcr-1 gene in this farm was not mainly due to clonal expansion. The mcr-1–positive E. coli isolates showed MICs of 4–16 mg/L for colistin. All of the mcr-1 producers displayed the multidrug resistance phenotype (Table 1).

Plasmid analysis and location of the mcr-1 genes

S1-PFGE and Southern hybridization analysis confirmed that the mcr-1 genes in the 26 E. coli isolates were located on plasmids ranging in size from 33 to 350 kb, whereas the mcr-1 gene in strain SHP33 was chromosomally located (Table 1). Two mcr-1–bearing plasmids coexisted in three isolates (SHP45, SHP41, and SHP7). In addition, two copies of the mcr-1 genes, one located on a chromosome and the other on a ~244-kb plasmid, were detected in strain SHP51. The mcr-1–bearing plasmids of the 23 E. coli isolates were successfully transferred to recipients by conjugation, and one transformant carrying mcr-1 positive plasmid was obtained by transformation. In seven transconjugants, ampicillin, cefotaxime, florfenicol, and fosfomycin resistance and reduced susceptibility to ciprofloxacin were co-transferred when compared to that in the parent recipient strain, which was due to the co-transfer of blaCTX−M−14, fosA3, floR, and oqxAB genes (Table 1). The IncI2, IncX4, and IncHI2/ST3 plasmids were detected in 5, 10, and 7 transconjugants, respectively. The other 4 mcr-1–bearing plasmids included one hybrid plasmid containing both IncY and IncHI2 replicons, one IncY plasmid, and two IncFII plasmids classified as F29:A-:B- and F53:A-:B- by replicon sequence typing (RST). Interestingly, all of the mcr-1–bearing IncHI2 plasmids were detected in isolates from nursery piglets (50–70 days old). The conjugation frequency varied from 10−2 to 10−6 transconjugants per recipient.

Given the large number of mcr-1–bearing IncI2, IncX4, and IncHI2 plasmids in this farm, ten plasmids comprising three IncI2-, three IncX4-, and four IncHI2-type plasmids were randomly chosen as representatives of each plasmid type to be sequenced. Among them, the complete sequence was obtained for the three IncX4 plasmids pHNSHP49, pHNSHP23 and pHNSHP10. These plasmids are highly similar to other mcr-1–bearing IncX4 plasmids such as pAF48 (KX032520; E. coli) in Switzerland, pESTMCR (KU743383; E. coli) from Estonia, pICBEC72Hmcr (CP015977; E. coli) in Brazil, pMCR1-NJ-IncX4 (KX447768; E. coli) in the United States, and pMCR1_Incx4 (KU761327; Klebsiella pneumoniae) from China. They all have a typical IncX4 backbone including the identical replication initiation protein gene pir, conjugal transfer protein gene trbM, taxABC, and pilX operons. The upstream insertion sequence ISApl1 flanking mcr-1 was consistently absent, and a previously described pap2 gene and the insertion sequence IS26 were present around mcr-1. No resistance genes other than mcr-1 were found (Figure S1a).

The remaining seven plasmids were also compared with other corresponding plasmids from various sources all over the world, using plasmid-related contigs. The IncI2-type plasmids, namely pHNSHP8, pHNSHP16, and pHNSHP50, showed 99% coverage to our previously reported plasmid pHNSHP45 (KP347127), the first identified mcr-1–bearing plasmid obtained from the same farm in 2013 (Liu et al., 2016). These three plasmids were also similar to other IncI2 plasmids such as pA31-12 (KX034083; E. coli; chicken), pZE36 (KY802014; E. coli; human), pEc_27COE18 (KY012275; E. coli; human), pECJS-61-63 (KX254342; E. coli; swine) from China, pMRY15-117_2DNA (AP017619; E. coli; unknown) from Japan, pOM97-mcr (KY693674; E. coli; human) from Oman, and pSLy21 (NZ_CP016405; E. coli; unknown) from the United States, all of which harbored a typical IncI2 backbone including a replicon region, plasmid stability function region, and conjugative transfer regions (tra and pil genes) (Figure S1b). The tnpA-IS683 region present in plasmid pHNSHP45 was also present in pHNSHP8 with the same insertion site and orientation, but was absent in other plasmids, including pHNSHP16 and pHNSHP50 in our study. As for IncHI2 plasmids pHNSHP26, pHNSHP41, pHNSHP47, pHNSHP48, they possessed most of the IncHI2 plasmid backbone sequences and were similar to each other, as well as to the previously reported plasmid pHNSHP45-2 (KU341381) (Zhi et al., 2016) with the same mcr-1-ISApl1 insertion sites and orientation, except that mcr-1 was flanked by two copies of ISApl1 with different insertion site on plasmid pHNSHP41. A slight difference was observed in the MDR regions of these plasmids, and part of the conjugative transfer regions (htdZKLVT and trhBCELKV) was absent in pHNSHP48 (Figure S1c).

Genetic background of mcr-1

PCR mapping and sequencing revealed that the genetic context of mcr-1 was diverse. Among the 10 plasmids, including 6 IncHI2 and 4 IncI2 plasmids, a single copy of ISApl1 was found to be located upstream of mcr-1. On 5 plasmids, the mcr-1 gene was flanked by two copies of ISApl1. In 10 plasmids, including all IncX4 plasmids, no copy of ISApl1 was present. In addition, using primers located on the IncX4, IncI2, or IncHI2 backbone and the mcr-1 gene, we confirmed that mcr-1 was inserted at the same sites on the IncX4, IncI2, and IncHI2 plasmids as that on plasmids pHNSHP23, pHNSHP45, and pHNSHP45-2, respectively, which indicated that pHNSHP23-like, pHNSHP45-like, and pHNSHP45-2-like plasmids were prevalent in this pig farm.

Plasmid stability and growth curve

The stability of plasmids pHNSHP45(IncI2), pHNSHP45-2(IncHI2), pHNSHP23(IncX4), pHNSHP17(IncY), and pHNSHP24(IncFII) was determined. No plasmid loss was detected during 96 h of competition experiments. pHNSHP45, pHNSHP45-2, pHNSHP23, and pHNSHP17 maintains stable in E. coli for at least 14 days of passage in an antibiotic-free environment. However, plasmid loss occurred in transformants E. coli DH5α/pHNSHP24 from day 5 (Figure 1). Growth kinetics of the transformants with these six plasmids and E. coli DH5α were also investigated. No obvious difference in growth was observed between the transformants and the recipient strain after 12 h assessment (Figure 2).

Figure 1.

Figure 1

Open in a new tab

In vitro stability of plasmids pHNSHP23, pHNSHP45-2, pHNSHP45, pHNSHP17 and pHNSHP24, data shown are the means of three independent assays. The error bars denote the 95% CI.

Figure 2.

Figure 2

Open in a new tab

Growth curve of E. coli DH5α and isogenic transformants. Curve indicates the mean of three independent experiments. The error bars denote the 95% CI.

Fitness effects of mcr-1 gene and mcr-1 plasmids in vitro

The impact of plasmids pHNSHP45, pHNSHP45-2, pHNSHP23, pHNSHP17 and pHNSHP24 on host fitness was evaluated by direct competition assays of plasmid-carrying E. coli DH5α against plasmid-free E. coli DH5α. The transformants with pHNSHP45(IncI2) or pHNSHP23(IncX4) outnumbered the parent E. coli DH5α strain after 24, 48, 72, and 96 h of cultivation. Plasmid pHNSHP45 in particular presented a high fitness advantage for its host, and the fitness was enhanced (16–91%) as serial passage. In contrast, plasmid pHNSHP45-2(IncHI2) imposed a slight fitness cost from 15% at 24 h to 28% at 96 h. For transformants E. coli DH5α/pHNSHP17 and E. coli DH5α/pHNSHP24, a slight fitness increase (2% and 11%, respectively) was observed at 24 h of passage, but the fitness was vanished following continuous growth, E. coli DH5α outcompete DH5α/pHNSHP17 or E. coli DH5α/pHNSHP24 after 48 or 72 h (Figure 3). Considering the fitness advantage of pHNSHP45 and pHNSHP23 described above and epidemiological success of IncI2, IncHI2 and IncX4 plasmids that mcr-1 located, we further compared the fitness of transformants with these three types of plasmids in a co-growth experiment, the outcome of plasmid-plasmid competition assays showed that under free-antimicrobials environment, E. coli DH5α acquiring pHNSHP45 outcompeted transformants with pHNSHP23 with a related fitness rate of 1.01–1.21 monitored from 24 to 96 h. While similar to the result mentioned above, pHNSHP45-2 plasmid was relative to a significant competition disadvantage vs. pHNSHP23 or pHNSHP45 (Figure 4).

Figure 3.

Figure 3

Open in a new tab

Relative fitness of transformants with mcr-1–bearing plasmids pHNSHP23, pHNSHP45-2, pHNSHP45, pHNSHP17, and pHNSHP24 in vitro competition.

Figure 4.

Figure 4

Open in a new tab

Growth competition in vitro between strains transformed with plasmids pHNSHP45 and pHNSHP45-2, pHNSHP23 and pHNSHP45-2 as well as pHNSHP45 and pHNSHP23.

Discussion

Previous literatures have suggested that multiple mobile elements especially plasmids contributed to the rapid spreading of mcr-1 (Li et al., 2017; Matamoros et al., 2017). Therefore, we characterized mcr-1-positive plasmids in this pig farm. The phnshp23-like (incx4), phnshp45-like (inci2), and phnshp45-2-like (inchi2) were the most common plasmids in the investigated strains, suggesting their dissemination was primarily responsible for the high rate of mcr-1 among e. Coli isolates in the pig farm. It is consistent with previous reports that the worldwide distribution of mcr-1 gene has mainly mediated by incx4, inci2, and inchi2-type plasmids (Falgenhauer et al., 2016; Poirel et al., 2016, 2017; Veldman et al., 2016; Li et al., 2017; Liu et al., 2017; Matamoros et al., 2017; Roschanski et al., 2017), with inci2 being the most prevalent plasmid backbone, followed by incx4 and inchi2. Thus, we further compared mcr-1–bearing incx4, inci2, and inchi2 plasmid content deposited in genbank, and found that mcr-1–bearing incx4 and inci2 plasmids detected in different countries were similar to the respective plasmids in our study, including the plasmid backbone and the mcr-1 insertion site. Although the insertion site of mcr-1 in inchi2 varied, almost all of the mcr-1–bearing inchi2 plasmids belonged to st3, especially those from china (Liu et al., 2017; Luo et al., 2017). In addition, all inchi2 plasmids that carried the blactx−m, fosa3, flor, and mcr-1 genes were identified among the isolates from nursery pigs. Considering the nursery pigs had been treated or fed with several antimicrobials, it seemed that the high selective pressure posed by the use of antimicrobials contributed to the spread of multidrug resistant inchi2 plasmids in the nursery pigs. However, because of the limitation in sample amount collected in each age group, this association still need to be further determined.

It is commonly considered that the variable fitness caused by plasmids depends on different host-plasmid combinations (Bouma and Lenski, 1988). Previous studies described that mcr-1-bearing plasmid can incur fitness cost on the bacterial host, but the fitness cost was caused by a IncHI2-type plasmid carrying mcr-1 (He et al., 2017). Thus, we systematically evaluated the fitness of a series of natural epidemic plasmids on the bacteria, and found that mcr-1–bearing IncI2, IncX4, and IncHI2 plasmids were quite stable and would not affect the growth of their hosts, which explained why these plasmids were dominant in this pig farm and worldwide. The result is in consistence with the previous reports that carriage of pGZ2-mcr (IncI2 type plasmid) or pECMCR-1101 (IncX4 type plasmid) would not impair the growth of recipient E. coli J53 or C600 (Kong et al., 2017; Zhang et al., 2017). Additionally, the fitness advantage of IncI2 and IncX4 plasmids on the host strain as well as the competitive advantage of IncI2 and IncX4 plasmids against IncHI2 plasmids (IncI2 plasmid type possess strongest competitive capability) further explained the fact that most reported mcr-1-bearing plasmids primarily belong to IncI2 and IncX4 plasmid types, especially IncI2 plasmids (Li et al., 2017; Matamoros et al., 2017) and their persistence in fattening pigs without the antibiotic exposure. Whereas the fitness cost imposed by IncHI2 plasmid type could give a clue to the less prevalence of IncHI2 plasmid type comparing to IncI2 and IncX4 and its missing in fattening pigs. Thus, IncI2 as well as IncX4 plasmids, due to their enhanced fitness of hosts, competition advantage over other plasmid types and plasmid stability, are able to replace other plasmids becoming capital vehicles for mcr-1 dissemination. Furthermore, a recent study has confirmed that the substantially increased expression of mcr-1 will impose a fitness burden on its E. coli host (Yang et al., 2017). The moderate MICs of colistin, primarily maintained among 4-8 mg/L in this study, and the fitness benefit mediated by mcr-1-bearing IncI2 and IncX4 plasmids as well as their epidemiological success further supported the notion that natural bacteria tend to keep a balance between the capability of resistance to colistin and its fitness impact on its host (Yang et al., 2017).

In conclusion, IncI2, IncX4, and IncHI2 were the major plasmid types driving the dissemination of mcr-1 in this farm. Plasmid stability and increased fitness or co-selection by other antimicrobials might contribute to the dissemination of the three epidemic mcr-1–positive plasmids (IncI2, IncX4, and IncHI2) in this farm and worldwide. Though China has now stopped colistin as a growth promoter (Walsh and Wu, 2016), the combination of multi-drug resistance capability of IncHI2-type plasmids and the fitness advantage conferred by the IncX4 and IncI2 plasmids indicated their potential for further dissemination with or without antibiotic selection pressure. We suggested that beside colistin, it is also essential to conduct prudent management for overall antimicrobials.

Ethics statement

This study was carried out in accordance with the recommendation of ethical guidelines of South China Agricultural University. Individual written informed consent for the use of fecal samples was obtained from all animal owners.

Author contributions

J-HL designed the study. RW, LFY, LXY, YL, and XC carried out the experiments. RW, LXY, JW, LL, and JY analyzed the data. LXY and J-HL wrote the manuscript. J-HL and JW revised the manuscript. All authors read and approved the final manuscript.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported in part by grants from the National Natural Science Foundation of China (No. 31625026 and 81661138002) and National Key Basic Research Program of China (No. 2013CB127200).

Supplementary material

The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmicb.2018.00331/full#supplementary-material

Click here for additional data file. (2.4MB, DOC)

References

  1. Alikhan N. F., Petty N. K., Ben Z. N., Beatson S. A. (2011). BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. 10.1186/1471-2164-12-402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Al-Tawfiq J. A., Laxminarayan R., Mendelson M. (2017). How should we respond to the emergence of plasmid-mediated colistin resistance in humans and animals? Int. J. Infect. Dis. 54, 77–84. 10.1016/j.ijid.2016.11.415 [DOI] [PubMed] [Google Scholar]
  3. Aziz R. K., Bartels D., Best A. A., DeJongh M., Disz T., Edwards R. A., et al. (2008). The RAST server: rapid annotations using subsystems technology. BMC Genomics 9:75. 10.1186/1471-2164-9-75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Baron S., Hadjadj L., Rolain J. M., Olaitan A. O. (2016). Molecular mechanisms of polymyxin resistance: knowns and unknowns. Int. J. Antimicrob. Agents 48, 583–591. 10.1016/j.ijantimicag.2016.06.023 [DOI] [PubMed] [Google Scholar]
  5. Bouma J. E., Lenski R. E. (1988). Evolution of a bacteria/plasmid association. Nature 335, 351–352. 10.1038/335351a0 [DOI] [PubMed] [Google Scholar]
  6. Bryksin A. V., Matsumura I. (2010). Rational design of a plasmid origin that replicates efficiently in both gram-positive and gram-negative bacteria. PLoS ONE 5:e13244. 10.1371/journal.pone.0013244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bush K., Courvalin P., Dantas G., Davies J., Eisenstein B., Huovinen P., et al. (2011). Tackling antibiotic resistance. Nat. Rev. Microbiol. 9, 894–896. 10.1038/nrmicro2693 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Carattoli A., Bertini A., Villa L., Falbo V., Hopkins K. L., Threlfall E. J. (2005). Identification of plasmids by PCR-based replicon typing. J. Microbiol. Methods. 63, 219–228. 10.1016/j.mimet.2005.03.018 [DOI] [PubMed] [Google Scholar]
  9. Clinical and Laboratory Standards Institute (2017). Performance Standards for Antimicrobial Susceptibility Testing: Twenty-fifth Informational Supplement. CLSI document M100-S27. Wayne, PA: CLSI. [Google Scholar]
  10. Cui M., Zhang J., Gu Z., Li R., Chan E. W., Yan M., et al. (2017). Prevalence and molecular characterization of mcr-1-positive Salmonella strains recovered from clinical specimens in China. Antimicrob. Agents Chemother. 61:e02471–16. 10.1128/AAC.02471-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Doumith M., Godbole G., Ashton P., Larkin L., Dallman T., Day M., et al. (2016). Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J. Antimicrob. Chemother. 71, 2300–2305. 10.1093/jac/dkw093 [DOI] [PubMed] [Google Scholar]
  12. Falgenhauer L., Waezsada S. E., Yao Y., Imirzalioglu C., Kasbohrer A., Roesler U., et al. (2016). Colistin resistance gene mcr-1 in extended-spectrum beta-lactamase-producing and carbapenemase-producing Gram-negative bacteria in Germany. Lancet Infect. Dis. 16, 282–283. 10.1016/S1473-3099(16)00009-8 [DOI] [PubMed] [Google Scholar]
  13. Foucault M. L., Courvalin P., Grillot-Courvalin C. (2009). Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 53, 2354–2359. 10.1128/AAC.01702-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. García-Fernández A., Carattoli A. (2010). Plasmid double locus sequence typing for IncHI2 plasmids, a subtyping scheme for the characterization of IncHI2 plasmids carrying extended-spectrum beta-lactamase and quinolone resistance genes. J. Antimicrob. Chemother. 65, 1155–1161. 10.1093/jac/dkq101 [DOI] [PubMed] [Google Scholar]
  15. He T., Wei R., Zhang L., Sun L., Pang M., Wang R., et al. (2017). Characterization of NDM-5-positive extensively resistant Escherichia coli isolates from dairy cows. Vet. Microbiol. 207, 153–158. 10.1016/j.vetmic.2017.06.010 [DOI] [PubMed] [Google Scholar]
  16. Hou J., Huang X., Deng Y., He L., Yang T., Zeng Z., et al. (2012). Dissemination of the fosfomycin resistance gene fosA3 with CTX-M beta-lactamase genes and rmtB carried on IncFII plasmids among Escherichia coli isolates from pets in China. Antimicrob. Agents Chemother. 56, 2135–2138. 10.1128/AAC.05104-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kong L. H., Lei C. W., Ma S. Z., Jiang W., Liu B. H., Wang Y. X., et al. (2017). Various sequence types of Escherichia coli isolates coharboring blaNDM-5 and mcr-1 genes from a commercial swine farm in China. Antimicrob. Agents Chemother. 61:e02167–16. 10.1128/AAC.02167-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Laxminarayan R., Duse A., Wattal C., Zaidi A. K., Wertheim H. F., Sumpradit N., et al. (2013). Antibiotic resistance-the need for global solutions. Lancet Infect. Dis. 13, 1057–1098. 10.1016/S1473-3099(13)70318-9 [DOI] [PubMed] [Google Scholar]
  19. Li B., Zhang Y., Wei J., Shao D., Liu K., Shi Y., et al. (2015). Characterization of a novel small plasmid carrying the florfenicol resistance gene floR in Haemophilus parasuis. J. Antimicrob. Chemother. 70, 3159–3161. 10.1093/jac/dkv230 [DOI] [PubMed] [Google Scholar]
  20. Li R., Xie M., Zhang J., Yang Z., Liu L., Liu X., et al. (2017). Genetic characterization of mcr-1-bearing plasmids to depict molecular mechanisms underlying dissemination of the colistin resistance determinant. J. Antimicrob. Chemother. 72, 393–401. 10.1093/jac/dkw411 [DOI] [PubMed] [Google Scholar]
  21. Liu B. T., Song F. J., Zou M., Zhang Q. D., Shan H. (2017). High incidence of Escherichia coli strains coharboring mcr-1 and blaNDM from chickens. Antimicrob. Agents Chemother. 61:e02347–16. 10.1128/AAC.02347-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Liu J. H., Wei S. Y., Ma J. Y., Zeng Z. L., Lu D. H., Yang G. X., et al. (2007). Detection and characterisation of CTX-M and CMY-2 beta-lactamases among Escherichia coli isolates from farm animals in Guangdong province of China. Int. J. Antimicrob. Agents 29, 576–581. 10.1016/j.ijantimicag.2006.12.015 [DOI] [PubMed] [Google Scholar]
  23. Liu Y. Y., Wang Y., Walsh T. R., Yi L. X., Zhang R., Spencer J., et al. (2016). Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect. Dis. 16, 161–168. 10.1016/S1473-3099(15)00424-7 [DOI] [PubMed] [Google Scholar]
  24. Luo J., Yao X., Lv L., Doi Y., Huang X., Huang S., et al. (2017). Emergence of mcr-1 in Raoultella ornithinolytica and Escherichia coli isolates from retail vegetables in China. Antimicrob. Agents Chemother. 61:e01139–17. 10.1128/AAC.01139-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Machuca J., Briales A., Labrador G., Díaz-de-Alba P., López-Rojas R., Docobo-Pérez F., et al. (2014). Interplay between plasmid-mediated and chromosomal-mediated fluoroquinolone resistance and bacterial fitness in Escherichia coli. J. Antimicrob. Chemother. 69, 3203–3215. 10.1093/jac/dku308 [DOI] [PubMed] [Google Scholar]
  26. Matamoros S., van Hattem J. M., Arcilla M. S., Willemse N., Melles D. C., Penders J., et al. (2017). Global phylogenetic analysis of Escherichia coli and plasmids carrying the mcr-1 gene indicates bacterial diversity but plasmid restriction. Sci. Rep. 7:15364. 10.1038/s41598-017-15539-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Poirel L., Jayol A., Nordmann P. (2017). Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin. Microbiol. Rev. 30, 557–596. 10.1128/CMR.00064-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Poirel L., Kieffer N., Brink A., Coetze J., Jayol A., Nordmann P. (2016). Genetic features of MCR-1-producing colistin-resistant Escherichia coli isolates in South Africa. Antimicrob. Agents Chemother. 60, 4394–4397. 10.1128/AAC.00444-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Roschanski N., Falgenhauer L., Grobbel M., Guenther S., Kreienbrock L., Imirzalioglu C., et al. (2017). Retrospective survey of mcr-1 and mcr-2 in German pig-fattening farms, 2011–2012. Int. J. Antimicrob. Agents 50, 266–271. 10.1016/j.ijantimicag.2017.03.007 [DOI] [PubMed] [Google Scholar]
  30. Tenover F. C., Arbeit R. D., Goering R. V., Mickelsen P. A., Murray B. E., Persing D. H., et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33, 2233–2239. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Veldman K., van Essen-Zandbergen A., Rapallini M., Wit B., Heymans R., van Pelt W., et al. (2016). Location of colistin resistance gene mcr-1 in Enterobacteriaceae from livestock and meat. J. Antimicrob. Chemother. 71, 2340–2342. 10.1093/jac/dkw181 [DOI] [PubMed] [Google Scholar]
  32. Villa L., Garcia-Fernandez A., Fortini D., Carattoli A. (2010). Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J. Antimicrob. Chemother. 65, 2518–2529. 10.1093/jac/dkq347 [DOI] [PubMed] [Google Scholar]
  33. Walsh T. R., Wu Y. (2016). China bans colistin as a feed additive for animals. Lancet Infect. Dis. 16, 1102–1103. 10.1016/S1473-3099(16)30329-2 [DOI] [PubMed] [Google Scholar]
  34. Wang J., Guo Z. W., Zhi C. P., Yang T., Zhao J. J., Chen X. J., et al. (2017). Impact of plasmid-borne oqxAB on the development of fluoroquinolone resistance and bacterial fitness in Escherichia coli. J. Antimicrob. Chemother. 72, 1293–1302. 10.1093/jac/dkw576 [DOI] [PubMed] [Google Scholar]
  35. Yang Q., Li M., Spiller O. B., Andrey D. O., Hinchliffe P., Li H., et al. (2017). Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms. Nat. Commun. 8:2054. 10.1038/s41467-017-02149-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Zhang Y., Liao K., Gao H., Wang Q., Wang X., Li H., et al. (2017). Decreased fitness and virulence in ST10 Escherichia coli harboring blaNDM-5 and mcr-1 against a ST4981 strain with blaNDM-5. Front Cell. Infect. Microbiol. 7:242. 10.3389/fcimb.2017.00242 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Zhao J., Chen Z., Chen S., Deng Y., Liu Y., Tian W., et al. (2010). Prevalence and dissemination of oqxAB in Escherichia coli isolates from animals, farmworkers, and the environment. Antimicrob. Agents Chemother. 54, 4219–4224. 10.1128/AAC.00139-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Zhi C., Lv L., Yu L. F., Doi Y., Liu J. H. (2016). Dissemination of the mcr-1 colistin resistance gene. Lancet Infect. Dis. 16, 292–293. 10.1016/S1473-3099(16)00063-3 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (2.4MB, DOC)

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES